Ornithine Infusion Injection (L-Aspartate-L-Ornithine)
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
MFDS item code 200500384 · Notified 2005.12.15
Detoxification treatment for severe liver disease (hepatic encephalopathy)
This medication is used for detoxification in severe liver disease, particularly in the pre-comatose and comatose state of hepatic encephalopathy. Hepatic encephalopathy is a condition where liver function is severely impaired, affecting brain function, and this medication helps treat it. Therefore, it plays an important role in improving the symptoms associated with serious liver disease.
As L-Aspartate-L-Ornithine, mix up to 40 g (8 ampoules) with an appropriate infusion solution for intravenous drip. Adjust according to symptoms.
This medication is in an ampoule form, so when opening the container, care should be taken as glass fragments may mix in. Particularly caution is needed when administering to children and the elderly. This medication should not be administered to patients with certain diseases. For example, it should not be used in patients with lactic acidosis, methanol poisoning, fructose-sorbitol intolerance, fructose-1,6-diphosphatase deficiency, and severe renal function impairment. Additionally, as it contains sulfite, it may cause allergic reactions or asthma attacks; hence, patients with asthma or those sensitive to sulfite should use it cautiously. During use, symptoms such as warmth at the back of the neck, nausea, or vomiting may occasionally occur. In cases of high dosage, blood and urine urea levels should be checked to monitor the patient's condition. If liver function is poor, the infusion rate should be adjusted to minimize discomfort or vomiting. It is important to slowly inject this medication intravenously. When stored, keep it out of reach of children, and do not transfer the medication from its original container to another container. This is to prevent misuse or deterioration of the medication's quality.
May cause allergic reactions such as sulfite anaphylaxis, and may trigger asthma attacks in some sensitive patients.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an opaque container that does not allow light in. Additionally, it should be stored at room temperature between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold places.
A brown ampoule containing a colorless to light yellow transparent liquid
10 mL/ampoule
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Prescription medication
Hanwha Pharm Co., Ltd.
L-Ornithine-L-Aspartate 3g
OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Daewon Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 15000mg
Solution · OTC medication
Joah Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.